Latham & Watkins represented Ouster, Inc. on the deal. Ouster, Inc., a leading lidar technology developer, executed an up to US$50 million structured debt facility from Hercules...
Ouster’s $50 Million Structured Debt Facility
BridgeBio Pharma’s Credit Facility Amendment
Latham & Watkins advised BridgeBio on the deal. BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, has entered into...
Impulse Dynamics’ $101 Million Financing Round
Latham & Watkins represented Kennedy Lewis Investment Management LLC in the transaction. Impulse Dynamics, a global medical device company a medical device company organized in Curacao...
Extra Space’s $400 Million Senior Notes Offering
Latham & Watkins represented Extra Space in the offering. Extra Space Storage Inc., a leading owner and operator of self-storage facilities in the United States and a...
Vapotherm’s $100 Million Debt Facility
Latham & Watkins represented SLR Investment Corp. in the transaction. Vapotherm, Inc., a global medical technology company focused on the development and commercialization of non-invasive technologies...
Coherus BioSciences’ $300 Million Credit Financing with Pharmakon Advisors
Latham & Watkins represented Coherus in the transaction. Coherus BioSciences, Inc. (Coherus or the Company) (Nasdaq: CHRS) has entered into a loan agreement with investment funds managed...
Mesoblast’s $90 Million Refinancing and Expansion of Senior Debt Facility
Latham & Watkins represented Mesoblast in the transaction. Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in stem cell medicines for inflammatory diseases, has announced that it has...
BridgeBio Pharma’s $750 Million Non-Dilutive Debt Financing
Latham & Watkins represented BridgeBio in the transaction. BridgeBio Pharma (Nasdaq: BBIO) (BridgeBio or the Company), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, executed a...
Paytm’s Initial Public Offering
Khaitan & Co. advised global co-ordinators and the book running lead managers on the deal, while IndusLaw and Trilegal advised the selling shareholders on the transaction....
Stonepeak Partners’ US$5.65 Billion Acquisition of The Cosmopolitan of Las Vegas
Latham & Watkins represented Stonepeak Partners in the transaction. Simpson Thacher advised Blackstone Real Estate Partners VII on the transaction. Blackstone (NYSE: BX) has announced that...
Connect Biopharma’s $219.9 Million Initial Public Offering
Latham & Watkins LLP and Maples and Calder represented Connect Biopharma in the transaction. Global Law Office and Davis Polk advised joint book-running managers. Connect Biopharma...